Enteral Nutrition (Medical Foods) Market, Revenue Share, Key Growth Trends, Major Players, and Forecast, 2022–2030

The global medical foods market size was USD 21.10 Billion in 2021 and is expected to register a revenue CAGR of 5.4% during the forecast period.

The global Enteral Nutrition (Medical Foods) market size is expected to reach USD 33.85 Billion in 2030 and register a revenue CAGR of 5.4% over the forecast period, according to latest report by Reports and Data. Rising demand for Enteral Nutrition (Medical Foods), due to rapid increase in geriatric population suffering from chronic diseases, and increasing use of Enteral Nutrition (Medical Foods) to control and manage diabetic neuropathy are expected to drive market revenue growth during the forecast period. Increasing collaborations and frequent product launches by key players are also expected to drive revenue growth of the market. Manufacturers are collaborating to come up with better products to satisfy global demand with rising awareness about Enteral Nutrition (Medical Foods). In addition, they are investing heavily in research development to manufacture better products and holding frequent promotional campaigns, which is supporting global market revenue growth and is expected to continue to do so during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1491

However, high costs and low availability of Enteral Nutrition (Medical Foods) in developing countries are expected to hamper market revenue growth. Enteral Nutrition (Medical Foods) are costly when compared to traditional food products. In addition, low investments in Enteral Nutrition (Medical Foods) in developing countries is leading to low production and less variation in products, resulting in low availability of Enteral Nutrition (Medical Foods). This, in turn, is increasing prices of Enteral Nutrition (Medical Foods) and thus, hampering revenue growth of the market.

  Some Key Highlights in the Report:

  • he powder segment is expected to account for largest revenue share during the forecast period. Increasing adoption of powdered Enteral Nutrition (Medical Foods) among geriatric and pediatric population and their ease of consumption are major factors driving revenue growth of this segment. In addition, large availability of powdered foods and the fact that powdered Enteral Nutrition (Medical Foods) can be administered through both oral and enteral routes to patients of all ages are expected to support revenue growth of this segment during the forecast period.
  • The diabetic neuropathy segment is expected to register the fastest CAGR during the forecast period, owing to rising cases of diabetes and increase in the number of patients that can develop neuropathy. In addition, various new initiatives to manage neuropathy through dietary measures is expected to drive revenue growth of this segment. Furthermore, 50% of adults suffering from diabetes are affected by peripheral neuropathy, and increasing incidence of this health condition is expected to support revenue growth of this segment during the forecast period.
  • North America accounted for largest revenue share in the global Enteral Nutrition (Medical Foods) market in 2021 and is expected to lead in terms of revenue contribution to the global market during the forecast period as well. The US has contributed the most to North America market revenue, while Canada and Mexico have also contributed considerably and are expected to continue to do so in the near future. Increasing incidence of chronic diseases in geriatric population is a major factor driving revenue growth of the North America market.

  Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product service portfolio. The Enteral Nutrition (Medical Foods) market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in RD, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.

Leading companies operating in the market are:

  •  Targeted Medical Pharma
  • Medtrition, Inc.
  • Nestle
  • Abbott Laboratories
  • Danone
  • Fresenius Kabi
  • Primus Pharmaceuticals, Inc.
  • Mead Johnson Company, LLC
  • Victus, Inc.
  • Meiji Holdings Co.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1491

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

  Enteral Nutrition (Medical Foods) Market Segmentation:

Type Outlook:

  • Pills
  • Powder
  • Liquid
  • Others

Application Outlook:

  • Chemotherapy-Induced Diarrhea
  • Diabetic Neuropathy
  • Pathogen Related Infections
  • Alzheimer’s Disease
  • Other

Sales Channel Outlook:

  • Online Sales
  • Institutional Sales
  • Retail Sales

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East Africa)

Some essential purposes of the Enteral Nutrition (Medical Foods) market research report:

  • Vital Developments: Custom investigation provides critical improvements to the Enteral Nutrition (Medical Foods) market, including RD, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.
  • Market Characteristics: The report contains Enteral Nutrition (Medical Foods) market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.
  • Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the Enteral Nutrition (Medical Foods) market by methods. Systematic tools and methodologies, for example, Porter’s Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the Enteral Nutrition (Medical Foods) market.
  • Convincingly, the Enteral Nutrition (Medical Foods) report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the Enteral Nutrition (Medical Foods) market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1491

Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

Increase in Incidence of Cushing Syndrome Disease is Expected to Drive Cushing Syndrome Market @ https://www.biospace.com/article/increase-in-incidence-of-cushing-syndrome-disease-is-expected-to-drive-cushing-syndrome-market-growth/

North America Cluster Headache Market @ https://www.biospace.com/article/north-america-cluster-headache-market-is-expected-to-register-highest-revenue-share-during-the-forecast-period-2022-2030/

North America Chronic Obstructive Pulmonary Disease (COPD) Market @ https://www.biospace.com/article/north-america-chronic-obstructive-pulmonary-disease-copd-market-is-expected-to-register-highest-revenue-share-during-the-forecast-period-2022-2030/

Increase in Cancer Incidence        https://www.biospace.com/article/increase-in-cancer-incidence-and-key-players-investing-in-r-and-d-is-expected-to-drive-burkitt-lymphoma-market-growth-till-2030-reports-and-data/

  About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs


16 Blog posts